2290 — Lung Fung group Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.87bn
- HK$2.80bn
- HK$3.28bn
Annual cashflow statement for Lung Fung group, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -25.2 | 181 | 218 | 327 |
| Depreciation | ||||
| Non-Cash Items | 37.5 | 55.2 | 90 | 38.8 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 576 | 864 | 980 | 1,102 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Payable / Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 716 | 1,234 | 1,462 | 1,695 |
| Capital Expenditures | -10.8 | -26 | -54.9 | -36.2 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -7.09 | -63.8 | -38.7 | -9.33 |
| Sale of Fixed Assets | ||||
| Change in Net Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -17.9 | -89.8 | -93.5 | -45.6 |
| Financing Cash Flow Items | -25.3 | -48.4 | -115 | -40.3 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -632 | -1,106 | -1,350 | -1,545 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 66.5 | 38.3 | 18.4 | 105 |